(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide

C263H281Br6F3N58O26 — CID 158239251

IUPAC(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)C=CCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/2C39H41BrN10O3.C38H44BrN7O4.C37H39BrN8O4.C37H42BrN7O4.C37H37F3N8O4.C36H37BrN8O4/c2*1-23-12-13-33(40)43-37(23)44-38(53)31-16-39-17-32(39)50(31)34(52)21-49-36-26(10-8-6-4-5-7-9-11-29-20-48(22-39)47-45-29)14-27(28-18-41-25(3)42-19-28)15-30(36)35(46-49)24(2)51;1-23-12-13-32(39)42-36(23)43-37(49)30-17-38-18-31(38)46(30)33(48)21-45-35-26(11-9-7-5-4-6-8-10-14-50-22-38)15-27(28-19-40-25(3)41-20-28)16-29(35)34(44-45)24(2)47;1-21-11-12-30(38)42-35(21)43-36(50)28-15-37-16-29(37)46(28)32(49)19-45-34-24(9-7-5-4-6-8-10-31(48)41-20-37)13-25(26-17-39-23(3)40-18-26)14-27(34)33(44-45)22(2)47;1-22-11-12-31(38)41-35(22)42-36(48)29-16-37-17-30(37)45(29)32(47)20-44-34-25(10-8-6-4-5-7-9-13-49-21-37)14-26(27-18-39-24(3)40-19-27)15-28(34)33(43-44)23(2)46;1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(25-16-41-22(3)42-17-25)13-26(33)32(46-47)21(2)49;1-20-10-11-29(37)41-34(20)42-35(49)27-14-36-15-28(36)45(27)31(48)18-44-33-23(8-6-4-5-7-9-30(47)40-19-36)12-24(25-16-38-22(3)39-17-25)13-26(33)32(43-44)21(2)46/h2*9,11-15,18-20,31-32H,4-8,10,16-17,21-22H2,1-3H3,(H,43,44,53);12-13,15-16,19-20,30-31H,4-11,14,17-18,21-22H2,1-3H3,(H,42,43,49);4-5,11-14,17-18,28-29H,6-10,15-16,19-20H2,1-3H3,(H,41,48)(H,42,43,50);11-12,14-15,18-19,29-30H,4-10,13,16-17,20-21H2,1-3H3,(H,41,42,48);6,8,10-13,16-17,27,29H,4-5,7,9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52);4,6,10-13,16-17,27-28H,5,7-9,14-15,18-19H2,1-3H3,(H,40,47)(H,41,42,49)/t2*31-,32+,39-;30-,31+,38-;28-,29+,37-;29-,30+,37-;27-,29+,36-;27-,28+,36-/m0000000/s1
InChIKeyGFIQUSZMFFNGOJ-YOAPIAMDSA-N
MW5206.94 g/mol
LogP41.27
Rot. Bonds28

About (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide

(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide (PubChem CID 158239251) has the molecular formula C263H281Br6F3N58O26 and a molecular weight of 5206.94 g/mol. Its IUPAC name is (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide.

Molecular Properties

Compound Name(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide
PubChem CID158239251
Molecular FormulaC263H281Br6F3N58O26
Molecular Weight5206.94 g/mol
Exact Mass5197.75
IUPAC Name(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)C=CCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/2C39H41BrN10O3.C38H44BrN7O4.C37H39BrN8O4.C37H42BrN7O4.C37H37F3N8O4.C36H37BrN8O4/c2*1-23-12-13-33(40)43-37(23)44-38(53)31-16-39-17-32(39)50(31)34(52)21-49-36-26(10-8-6-4-5-7-9-11-29-20-48(22-39)47-45-29)14-27(28-18-41-25(3)42-19-28)15-30(36)35(46-49)24(2)51;1-23-12-13-32(39)42-36(23)43-37(49)30-17-38-18-31(38)46(30)33(48)21-45-35-26(11-9-7-5-4-6-8-10-14-50-22-38)15-27(28-19-40-25(3)41-20-28)16-29(35)34(44-45)24(2)47;1-21-11-12-30(38)42-35(21)43-36(50)28-15-37-16-29(37)46(28)32(49)19-45-34-24(9-7-5-4-6-8-10-31(48)41-20-37)13-25(26-17-39-23(3)40-18-26)14-27(34)33(44-45)22(2)47;1-22-11-12-31(38)41-35(22)42-36(48)29-16-37-17-30(37)45(29)32(47)20-44-34-25(10-8-6-4-5-7-9-13-49-21-37)14-26(27-18-39-24(3)40-19-27)15-28(34)33(43-44)23(2)46;1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(25-16-41-22(3)42-17-25)13-26(33)32(46-47)21(2)49;1-20-10-11-29(37)41-34(20)42-35(49)27-14-36-15-28(36)45(27)31(48)18-44-33-23(8-6-4-5-7-9-30(47)40-19-36)12-24(25-16-38-22(3)39-17-25)13-26(33)32(43-44)21(2)46/h2*9,11-15,18-20,31-32H,4-8,10,16-17,21-22H2,1-3H3,(H,43,44,53);12-13,15-16,19-20,30-31H,4-11,14,17-18,21-22H2,1-3H3,(H,42,43,49);4-5,11-14,17-18,28-29H,6-10,15-16,19-20H2,1-3H3,(H,41,48)(H,42,43,50);11-12,14-15,18-19,29-30H,4-10,13,16-17,20-21H2,1-3H3,(H,41,42,48);6,8,10-13,16-17,27,29H,4-5,7,9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52);4,6,10-13,16-17,27-28H,5,7-9,14-15,18-19H2,1-3H3,(H,40,47)(H,41,42,49)/t2*31-,32+,39-;30-,31+,38-;28-,29+,37-;29-,30+,37-;27-,29+,36-;27-,28+,36-/m0000000/s1
InChIKeyGFIQUSZMFFNGOJ-YOAPIAMDSA-N
XLogP41.27
TPSA1027.97 Ų
H-Bond Donors10
H-Bond Acceptors67
Rotatable Bonds28
Heavy Atoms356
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5005206.94
LogP ≤ 541.27
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1067

Analyze (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide?
The IUPAC name of (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide (CID 158239251) is (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide.
What is the SMILES notation for (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide?
The canonical SMILES for (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide is CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)C=CCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(C(F)(F)F)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC=Cc1cn(nn1)C[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCCCOC[C@@]13C[C@@H](C(=O)Nc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.
What is the InChIKey of (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide?
The InChIKey is GFIQUSZMFFNGOJ-YOAPIAMDSA-N. The full InChI is InChI=1S/2C39H41BrN10O3.C38H44BrN7O4.C37H39BrN8O4.C37H42BrN7O4.C37H37F3N8O4.C36H37BrN8O4/c2*1-23-12-13-33(40)43-37(23)44-38(53)31-16-39-17-32(39)50(31)34(52)21-49-36-26(10-8-6-4-5-7-9-11-29-20-48(22-39)47-45-29)14-27(28-18-41-25(3)42-19-28)15-30(36)35(46-49)24(2)51;1-23-12-13-32(39)42-36(23)43-37(49)30-17-38-18-31(38)46(30)33(48)21-45-35-26(11-9-7-5-4-6-8-10-14-50-22-38)15-27(28-19-40-25(3)41-20-28)16-29(35)34(44-45)24(2)47;1-21-11-12-30(38)42-35(21)43-36(50)28-15-37-16-29(37)46(28)32(49)19-45-34-24(9-7-5-4-6-8-10-31(48)41-20-37)13-25(26-17-39-23(3)40-18-26)14-27(34)33(44-45)22(2)47;1-22-11-12-31(38)41-35(22)42-36(48)29-16-37-17-30(37)45(29)32(47)20-44-34-25(10-8-6-4-5-7-9-13-49-21-37)14-26(27-18-39-24(3)40-19-27)15-28(34)33(43-44)23(2)46;1-20-10-11-28(37(38,39)40)44-34(20)45-35(52)27-14-36-15-29(36)48(27)31(51)18-47-33-23(8-6-4-5-7-9-30(50)43-19-36)12-24(25-16-41-22(3)42-17-25)13-26(33)32(46-47)21(2)49;1-20-10-11-29(37)41-34(20)42-35(49)27-14-36-15-28(36)45(27)31(48)18-44-33-23(8-6-4-5-7-9-30(47)40-19-36)12-24(25-16-38-22(3)39-17-25)13-26(33)32(43-44)21(2)46/h2*9,11-15,18-20,31-32H,4-8,10,16-17,21-22H2,1-3H3,(H,43,44,53);12-13,15-16,19-20,30-31H,4-11,14,17-18,21-22H2,1-3H3,(H,42,43,49);4-5,11-14,17-18,28-29H,6-10,15-16,19-20H2,1-3H3,(H,41,48)(H,42,43,50);11-12,14-15,18-19,29-30H,4-10,13,16-17,20-21H2,1-3H3,(H,41,42,48);6,8,10-13,16-17,27,29H,4-5,7,9,14-15,18-19H2,1-3H3,(H,43,50)(H,44,45,52);4,6,10-13,16-17,27-28H,5,7-9,14-15,18-19H2,1-3H3,(H,40,47)(H,41,42,49)/t2*31-,32+,39-;30-,31+,38-;28-,29+,37-;29-,30+,37-;27-,29+,36-;27-,28+,36-/m0000000/s1.
What are the key properties of (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide?
(1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide has a molecular weight of 5206.94 g/mol, XLogP of 41.27, 28 rotatable bonds, 10 hydrogen bond donors, and 67 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-4,21-dioxo-3,18,19,22-tetrazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-26-carboxamide;(1R,22R,25S)-16-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-8,11(26),12,14,16-pentaene-25-carboxamide;bis((1R,26R,29S)-20-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-17-(2-methylpyrimidin-5-yl)-24-oxo-3,4,5,21,22,25-hexazahexacyclo[23.2.2.13,6.115,19.01,26.022,30]hentriaconta-4,6(31),7,15(30),16,18,20-heptaene-29-carboxamide);(1S,23R,26S)-17-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-14-(2-methylpyrimidin-5-yl)-21-oxo-3-oxa-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-26-carboxamide;(1S,24R,27S)-18-acetyl-N-(6-bromo-3-methyl-2-pyridinyl)-15-(2-methylpyrimidin-5-yl)-22-oxo-3-oxa-19,20,23-triazapentacyclo[21.2.2.113,17.01,24.020,28]octacosa-13(28),14,16,18-tetraene-27-carboxamide;(1R,22R,25S)-16-acetyl-13-(2-methylpyrimidin-5-yl)-N-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-9,11(26),12,14,16-pentaene-25-carboxamide is sourced from PubChem (CID 158239251), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).